{"nct_id":"NCT00290771","title":"Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)","status":"TERMINATED","status_verified_date":"2011-04","start_date":"2006-02","start_date_type":null,"primary_completion_date":"2008-08","primary_completion_date_type":"ACTUAL","completion_date":"2008-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}